Aktie A3ESFA UNIVERSE PHARMACEUTICALS INC
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Universe Pharmaceuticals INC

Aktien

A3ESFA

KYG9442G1120

UPC

Verzögert Nasdaq
Andere Börsenplätze
 18:07:51 30.04.2024 		% 5 Tage % 1. Jan.
2,29 USD -4,18 % Intraday Chart für Universe Pharmaceuticals INC +4,09 % +13,93 %
30.01. Universe Pharmaceuticals INC berichtet über die Ergebnisse für das am 30. September 2023 zu Ende gegangene Geschäftsjahr CI
2023 Top Premarket Gainers MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Top Premarket Decliners
Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results
Universe Pharmaceuticals INC Reports Earnings Results for the Full Year Ended September 30, 2023
Top Premarket Gainers
Universe Pharmaceuticals INC Reports Earnings Results for the Half Year Ended March 31, 2023
Universe Pharmaceuticals : Receipt of Nasdaq Notification Regarding Compliance with Nasdaq Minimum Bid Price Requirement - Form 6-K
Universe Pharmaceuticals Receives Nasdaq Non-Compliance Notice
Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares
Universe Pharmaceuticals INC Announces Share Consolidation
Universe Pharmaceuticals : Results of the Universe Pharmaceuticals INC 2023 Annual General Meeting - Form 6-K
Universe Pharmaceuticals INC Announces Board Changes
Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Universe Pharmaceuticals INC Reports Earnings Results for the Full Year Ended September 30, 2022
Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19
Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19
Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price Requirement
Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price Requirement
Universe Pharmaceuticals : Results of the Universe Pharmaceuticals INC 2022 Annual General Meeting - Form 6-K
Universe Pharmaceuticals INC Reports Earnings Results for the Half Year Ended March 31, 2022
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3ESFA Aktie
  4. Nachrichten Universe Pharmaceuticals INC
  5. Andere Sprachen